Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(1-Naphthoyl)indole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

109555-87-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 109555-87-5 Structure
  • Basic information

    1. Product Name: 3-(1-Naphthoyl)indole
    2. Synonyms: 3-(1-Naphthoyl)indole;(1H-Indol-3-yl)-naphthalen-1-yl-methanone;Ketone indol-3-yl 1-naphthyl;1H-Indol-3-yl-1-naphthalenylmethanone;Indol-3-yl 1-Naphthyl Ketone;Methanone, 1H-indol-3-yl-1-naphthalenyl-;(1H-indol-3-yl)(naphthalene-1-yl)Methanone;3-(1-naphthylcarbonyl)indole
    3. CAS NO:109555-87-5
    4. Molecular Formula: C19H13NO
    5. Molecular Weight: 271.318
    6. EINECS: 207-791-3
    7. Product Categories: Aromatics;Heterocycles;Indole Derivatives;Metabolites & Impurities
    8. Mol File: 109555-87-5.mol
    9. Article Data: 14
  • Chemical Properties

    1. Melting Point: 236℃
    2. Boiling Point: 512.233 °C at 760 mmHg
    3. Flash Point: 263.978 °C
    4. Appearance: Pale pink solid
    5. Density: 1.267
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.738
    8. Storage Temp.: Refrigerator
    9. Solubility: DMSO (Slightly), Methanol (Slightly)
    10. PKA: 15.22±0.30(Predicted)
    11. CAS DataBase Reference: 3-(1-Naphthoyl)indole(CAS DataBase Reference)
    12. NIST Chemistry Reference: 3-(1-Naphthoyl)indole(109555-87-5)
    13. EPA Substance Registry System: 3-(1-Naphthoyl)indole(109555-87-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 109555-87-5(Hazardous Substances Data)

109555-87-5 Usage

Chemical Properties

Pale Pink Solid

Uses

Metabolite of JWH-018 (P283650).

Check Digit Verification of cas no

The CAS Registry Mumber 109555-87-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,5,5 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 109555-87:
(8*1)+(7*0)+(6*9)+(5*5)+(4*5)+(3*5)+(2*8)+(1*7)=145
145 % 10 = 5
So 109555-87-5 is a valid CAS Registry Number.
InChI:InChI=1/C19H13NO/c21-19(17-12-20-18-11-4-3-9-15(17)18)16-10-5-7-13-6-1-2-8-14(13)16/h1-12,20H

109555-87-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1-Naphthoyl)indole

1.2 Other means of identification

Product number -
Other names 1H-indol-3-yl(naphthalen-1-yl)methanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:109555-87-5 SDS

109555-87-5Relevant articles and documents

Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors

Dvorácskó, Szabolcs,Keresztes, Attila,Mollica, Adriano,Stefanucci, Azzurra,Macedonio, Giorgia,Pieretti, Stefano,Zádor, Ferenc,Walter, Fruzsina R.,Deli, Mária A.,Kékesi, Gabriella,Bánki, László,Tuboly, Gábor,Horváth, Gy?ngyi,T?mb?ly, Csaba

, p. 571 - 588 (2019)

In order to obtain novel pharmacological tools and to investigate a multitargeting analgesic strategy, the CB1 and CB2 cannabinoid receptor agonist JWH-018 was conjugated with the opiate analgesic oxycodone or with an enkephalin related tetrapeptide. The opioid and cannabinoid pharmacophores were coupled via spacers of different length and chemical structure. In vitro radioligand binding experiments confirmed that the resulting bivalent compounds bound both to the opioid and to the cannabinoid receptors with moderate to high affinity. The highest affinity bivalent derivatives 11 and 19 exhibited agonist properties in [35S]GTPγS binding assays. These compounds activated MOR and CB (11 mainly CB2, whereas 19 mainly CB1) receptor-mediated signaling, as it was revealed by experiments using receptor specific antagonists. In rats both 11 and 19 exhibited antiallodynic effect similar to the parent drugs in 20 μg dose at spinal level. These results support the strategy of multitargeting G-protein coupled receptors to develop lead compounds with antinociceptive properties.

Concise Synthesis of Potential 4-Hydroxy-5-fluoropentyl Side-Chain Metabolites of Four Synthetic Cannabinoids

Dahlén, Johan,Konradsson, Peter,Liu, Huiling,Rexander, Anders,Vestling, Erik,Wallgren, Jakob,Wu, Xiongyu

, p. 517 - 520 (2020)

Synthetic cannabinoids are a group of compounds that act on the CB1 receptor and are used illicitly as substitutes for cannabis. Given the rapid and extensive metabolism of synthetic cannabinoids, urinary biomarkers are essential if proof of drug intake is to be obtained in forensic laboratories. To identify good biomarker candidates, the metabolism of synthetic cannabinoids must be studied and reference standards need to be acquired. Studies on the metabolism of synthetic cannabinoids containing a terminally fluorinated pentyl side chain have shown that hydroxylation can occur at the four position of the side chain. This makes the 4-hydroxy-5-fluoropentyl side-chain metabolite a good urinary biomarker for proving intake of the corresponding parent drug, as this compound cannot be formed from its nonfluorinated analogue. Here, a concise synthetic route to the 4-hydroxy-5-fluoropentyl side-chain metabolites of the synthetic cannabinoids STS-135, MAM-2201, AM-2201, and XLR-11 is reported.

Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073

Cooper, Ziva D.,Poklis, Justin L.,Liu, Fei

, p. 92 - 100 (2018)

Synthetic cannabinoids (SCs) are a significant public health concern given their widespread use and severe effects associated with intoxication. However, there is a paucity of controlled human studies investigating the behavioral and physiological effects and pharmacokinetics of these compounds. Designing a reliable method to administer consistent, concentration-dependent synthetic cannabinoids is an integral component of controlled study of these compounds. Further, optimizing methods to assess the parent compounds and metabolites in plasma is critical in order to be able to establish their pharmacokinetics after administration. To develop a reliable method to administer smokable, concentration-dependent SCs, cigarettes were prepared with plant matter adulterated with increasing concentrations of the first generation cannabinoids found in SC products, JWH-018 and JWH-073. Cigarettes were assessed 1–6 months after preparation using ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) to determine compound stability over time and concentration consistency throughout the cigarettes. Optimal conditions to detect metabolites in human plasma as a function of storage temperature (?4 °C to ?80 °C) and time (24 h - 1 month) were also determined. Analyses verified that the method utilized to develop SC cigarettes yielded consistent, concentration-dependent products within 25% of the expected concentrations. JWH-018, JWH-073 and metabolites in spiked plasma were stable under the time and temperature conditions; concentrations were within ±20% of target values. These studies provide techniques and methods to conduct controlled investigations of the dose-dependent effects of first generation SCs to begin understanding risks associated with use. This article is part of the Special Issue entitled ‘Designer Drugs and Legal Highs.’

Synthesis of 3-acylindoles: via copper-mediated oxidative decarbethoxylation of ethyl arylacetates

Jaiswal, Anjali,Sharma, Anup Kumar,Singh, Krishna Nand

supporting information, p. 1623 - 1628 (2020/03/06)

An efficient regioselective C-3 acylation of free indoles (N-H) has been accomplished via oxidative decarbethoxylation of easily available ethyl arylacetates using Cu(OAc)2 and KOtBu in DMSO.

A novel synthesis of N-hydroxy-3-aroylindoles and 3-aroylindoles

Ieronimo, Gabriella,Palmisano, Giovanni,Maspero, Angelo,Marzorati, Alessandro,Scapinello, Luca,Masciocchi, Norberto,Cravotto, Giancarlo,Barge, Alessandro,Simonetti, Marco,Ameta, Keshav Lalit,Nicholas, Kenneth M.,Penoni, Andrea

, p. 6853 - 6859 (2018/10/20)

A straightforward indole synthesis via annulation of C-nitrosoaromatics with conjugated terminal alkynones was realised achieving a simple, highly regioselective, atom- and step economical access to 3-aroylindoles in moderate to good yields. Further functionalizations of indole scaffolds were investigated and an easy way to JWH-018, a synthetic cannabinoid, was achieved.

Detection of synthetic cannabinoids

-

Page/Page column, (2014/03/22)

The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from immunogens enable said methods and kits.

A novel microwave-irradiated solvent-free 3-acylation of indoles on alumina

Lai, Qiu Yu,Liao, Rong Su,Wu, Shao Yong,Zhang, Jia Xin,Duan, Xin Hong

, p. 4069 - 4076 (2013/12/04)

A simple and efficient 3-acylation of indoles under microwave-heated and solvent-free conditions is developed. This general procedure uses neutral Al2O3 as a new, green and reusable catalyst giving good to high yields within short reaction times. Utilizing such an environmentally- benign methodology, a variety of indoles bearing electron-releasing or electron-withdrawing groups were conveniently acylated.

Detection of Synthetic Cannabinoids

-

Page/Page column 8, (2012/08/28)

The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.

Detection of Synthetic Cannabinoids

-

, (2012/08/28)

The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 109555-87-5